Inogen's Study Demonstrating The Association Of Portable Oxygen Therapy With Decreased Mortality And Increased Cost-Effectiveness Ratio Published In The Journal Pulmonary Therapy
Portfolio Pulse from Benzinga Newsdesk
Inogen, Inc. (NASDAQ:INGN) published a study in the journal Pulmonary Therapy showing that portable oxygen concentrators (POCs) are associated with increased survival and cost-effectiveness compared to other long-term oxygen therapies. The study, using data from the French national healthcare system, analyzed over 244,000 patients and found that POCs improved survival rates and had similar healthcare resource use compared to stationary concentrators, compressed tanks, and liquid oxygen.
June 03, 2024 | 8:20 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Inogen's study demonstrates that portable oxygen concentrators (POCs) are associated with increased survival and cost-effectiveness compared to other long-term oxygen therapies. This positive outcome could boost investor confidence and potentially increase the stock price.
The study's findings highlight the benefits of Inogen's portable oxygen concentrators, which could lead to increased demand for their products. This positive news is likely to boost investor confidence and potentially increase the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100